US Patent 8129343 Acylated GLP-1 compounds

Patent 8129343 was granted and assigned to Novo Nordisk on March, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

81293430

Patent Inventor Names

Jesper Lau0

Paw Bloch0

Thomas Kruse Hansen0

Date of Patent

March 6, 2012

Patent Application Number

119088340

Date Filed

March 20, 2006

Patent Citations Received

‌

US Patent 11752198 GLP-1 compositions and uses thereof

‌

US Patent 11865160 Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof

Patent Primary Examiner

‌

Marcela M Cordero Garcia

Patent abstract

Protracted GLP-1 compounds and therapeutic uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8129343 Acylated GLP-1 compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API